Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment

dc.contributor.author	Vázquez Estévez, Sergio
dc.contributor.author	Varela Ferreiro, Silvia
dc.contributor.author	Campos Balea, Begoña
dc.contributor.author	Álvarez Gómez, Elena
dc.contributor.author	Quintero Aldana, Guillermo
dc.contributor.author	Mel Lorenzo, José Ramón
dc.date.accessioned	2017-06-07T07:19:19Z
dc.date.available	2017-06-07T07:19:19Z
dc.date.issued	2012
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/5081
dc.language.iso	eng
dc.title	Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment
dc.type	Publicación de congreso
dc.authorsophos	Sergio V.E.
dc.authorsophos	Varela S.
dc.authorsophos	Campos B.
dc.authorsophos	Alvarez E.
dc.authorsophos	Quntero G.
dc.authorsophos	Mel J.R.
dc.identifier.sophos	8258
dc.issue.number	15 suppl.1
dc.journal.title	Journal Of Clinical Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Lugo - Hospital Universitario Lucus Augusti::Oncoloxía médica
dc.page.initial	var.pag
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	30

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.